B cells, identified by releasing IL-10, IL-35, and TGF-β, had been shown to limit inflammation, autoimmune disease, and tumor, while B cells, identified by secreting TNF-α, IL-6, and GM-CSF, had been shown to promote disease [14, 41–44]. Here, TGFB1 is linked to neoplasm.